Enriqueta Felip, MD, PhD / David Harpole, MD - Reflecting on the Role of Perioperative Immunotherapeutic Regimens for Resectable Non–Small-Cell Lung Cancer: Evaluating the Evidence to Determine Better Pathways of Care
Listen now
Description
Please visit answersincme.com/XQE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts in non–small-cell lung cancer (NSCLC) discuss perioperative immunotherapeutic approaches in patients with resectable NSCLC. Upon completion of this activity, participants should be better able to: Describe the rationale for perioperative immunotherapeutic approaches in patients with resectable NSCLC; Outline the clinical impact of perioperative immunotherapeutic approaches in patients with resectable NSCLC; and Identify practical strategies to optimize the care of patients with resectable NSCLC, based on the current and emerging clinical data.
More Episodes
Please visit answersincme.com/PES860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonary disease discusses the implications of the latest evidence on biologic therapies targeting type 2 inflammation for the...
Published 09/20/24
Please visit answersincme.com/BXP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in thoracic oncology discusses B7-H3–directed antibody-drug conjugates as a treatment strategy for small-cell lung cancer. Upon...
Published 09/09/24